TY - JOUR
KW - Alcoholism/drug therapy
KW - Drug Monitoring
KW - Drug Overdose/prevention & control
KW - Humans
KW - Opioid-Related Disorders/drug therapy
KW - Prescription Drugs/therapeutic use
KW - Primary Health Care
AU - J. Lee
AU - T. F. Kresina
AU - M. Campopiano
AU - R. Lubran
AU - H. W. Clark
A1 - 
AB - Substance-related and addictive disorders are chronic relapsing conditions that substantially impact public health. Effective treatments for these disorders require addressing substance use/dependence comprehensively as well as other associated comorbidities. Comprehensive addressing of substance use in a medical setting involves screening for substance use, addressing substance use directly with the patient, and formulating an appropriate intervention. For alcohol dependence and opioid dependence, pharmacotherapies are available that are safe and effective when utilized in a comprehensive treatment paradigm, such as medication assisted treatment. In primary care, substance use disorders involving alcohol, illicit opioids, and prescription opioid abuse are common among patients who seek primary care services. Primary care providers report low levels of preparedness and confidence in identifying substance-related and addictive disorders and providing appropriate care and treatment. However, new models of service delivery in primary care for individuals with substance-related and addictive disorders are being developed to promote screening, care and treatment, and relapse prevention. The education and training of primary care providers utilizing approved medications for the treatment of alcohol use disorders and opioid dependence in a primary care setting would have important public health impact and reduce the burden of alcohol abuse and opioid dependence.
BT - BioMed research international
C5 - Opioids & Substance Use; Education & Workforce
CY - United States
DO - 10.1155/2015/137020
JF - BioMed research international
N2 - Substance-related and addictive disorders are chronic relapsing conditions that substantially impact public health. Effective treatments for these disorders require addressing substance use/dependence comprehensively as well as other associated comorbidities. Comprehensive addressing of substance use in a medical setting involves screening for substance use, addressing substance use directly with the patient, and formulating an appropriate intervention. For alcohol dependence and opioid dependence, pharmacotherapies are available that are safe and effective when utilized in a comprehensive treatment paradigm, such as medication assisted treatment. In primary care, substance use disorders involving alcohol, illicit opioids, and prescription opioid abuse are common among patients who seek primary care services. Primary care providers report low levels of preparedness and confidence in identifying substance-related and addictive disorders and providing appropriate care and treatment. However, new models of service delivery in primary care for individuals with substance-related and addictive disorders are being developed to promote screening, care and treatment, and relapse prevention. The education and training of primary care providers utilizing approved medications for the treatment of alcohol use disorders and opioid dependence in a primary care setting would have important public health impact and reduce the burden of alcohol abuse and opioid dependence.
PP - United States
PY - 2015
SN - 2314-6141
SP - 137020
T1 - Use of pharmacotherapies in the treatment of alcohol use disorders and opioid dependence in primary care
T2 - BioMed research international
TI - Use of pharmacotherapies in the treatment of alcohol use disorders and opioid dependence in primary care
U1 - Opioids & Substance Use; Education & Workforce
U2 - 25629034
U3 - 10.1155/2015/137020
VL - 2015
VO - 2314-6141
Y1 - 2015
ER -